PM

Prosight Management Portfolio holdings

AUM $416M
1-Year Est. Return 4.49%
This Quarter Est. Return
1 Year Est. Return
+4.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$416M
AUM Growth
+$6.43M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$21.8M
2
+$8.43M
3
+$8.03M
4
BSX icon
Boston Scientific
BSX
+$7.43M
5
SEM icon
Select Medical
SEM
+$6.69M

Top Sells

1
+$34.3M
2
+$21.6M
3
+$14M
4
ARGX icon
argenx
ARGX
+$13.8M
5
ADCT icon
ADC Therapeutics
ADCT
+$12M

Sector Composition

1 Healthcare 99.88%
2 Industrials 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
26
Corbus Pharmaceuticals
CRBP
$195M
$4.34M 1.01%
343,400
-236,493
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$345M
$4.13M 0.96%
1,267,965
-312,623
PRCT icon
28
Procept Biorobotics
PRCT
$1.7B
$2.75M 0.64%
+76,991
ALGN icon
29
Align Technology
ALGN
$10.6B
$2.43M 0.57%
+19,442
ARGX icon
30
argenx
ARGX
$54.7B
$2.43M 0.57%
3,300
-18,700
TWST icon
31
Twist Bioscience
TWST
$1.85B
$2.11M 0.49%
+75,000
AKRO icon
32
Akero Therapeutics
AKRO
$4.48B
$1.86M 0.43%
+39,072
CTMX icon
33
CytomX Therapeutics
CTMX
$696M
$1.8M 0.42%
564,800
-2,952,313
SGHT icon
34
Sight Sciences
SGHT
$437M
$1.51M 0.35%
439,941
-431,746
OKUR
35
OnKure Therapeutics
OKUR
$39.7M
$737K 0.17%
267,959
+108,267
SDGR icon
36
Schrodinger
SDGR
$1.25B
$699K 0.16%
+34,830
RNTX
37
Rein Therapeutics
RNTX
$39.2M
$650K 0.15%
567,898
+139,979
TBI
38
Trueblue
TBI
$147M
$487K 0.11%
+79,476
PRTA icon
39
Prothena Corp
PRTA
$585M
$195K 0.05%
20,000
-247,800
PLRX icon
40
Pliant Therapeutics
PLRX
$95.9M
$30.3K 0.01%
20,487
-816,913
ACTU
41
Actuate Therapeutics
ACTU
$168M
$5.92K ﹤0.01%
+885
AXGN icon
42
Axogen
AXGN
$1.31B
– –
-282,809
CORT icon
43
Corcept Therapeutics
CORT
$8.2B
– –
0
ERAS icon
44
Erasca
ERAS
$854M
– –
-240,295
LIVN icon
45
LivaNova
LIVN
$3.48B
– –
-140,000
LNTH icon
46
Lantheus
LNTH
$3.85B
– –
-34,576
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$3.75B
– –
-200,000
MURA icon
48
Mural Oncology
MURA
$35M
– –
-900,000
PEPG icon
49
PepGen
PEPG
$412M
– –
-243,980
UNH icon
50
UnitedHealth
UNH
$297B
– –
-110,000
1
2